Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Wickham Labs Announces Upcoming Webinar on Regulatory Changes in Medical Device Development

Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical Device Development.
We would like to invite you to our latest upcoming webinar, “Regulatory Changes in Medical Device Development” which will take place at 3PM London / 10AM New York, 23rd of May 2018.
During this webinar, our technical experts will provide an overview of the current state of the medical device industry as it consolidates during a time when the market is expanding with unparalleled opportunities for the invention of new devices. They will also cover risk assessments, safety dossier preparation, and any laboratory testing necessary to determine the safety profile of the device.
Join us to understand the recent changes and their impact on your medical device development portfolio. Registration is now open for access, this and more details about the webinar are located via our landing page here.

Disclaimer: Patient Guard Ltd and Wickham Laboratories Ltd are independent companies collaborating on ad hoc projects and the co-presenting of this webinar is not an indication of partnership.
Company Overview
As a GMP/GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy. We conduct business with clients worldwide and the combined expertise of our laboratory technicians and managers enables us to be fully conversant with global regulatory expectations.
We are committed to providing a quality testing service, combining high levels of client satisfaction together with the maintenance of appropriate accreditation. This and the continual pursuit of delivering excellence remain central to our business.
We are routinely inspected by the MHRA, FDA and Home Office, and offer the opportunity for clients to conduct audits on a regular basis.

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025